The Nishinihon Journal of Dermatology
Online ISSN : 1880-4047
Print ISSN : 0386-9784
ISSN-L : 0386-9784
Search
Advanced search
OR
Browse
Search
Volume 85, Issue 4
Displaying 1-14 of 14 articles from this issue
Show all abstracts
    • |<
    • <
    • 1
    • >
    • >|
Index
Color Atlas
Mini Review
Clinical Case Reports
Therapy
Dermatologists around the World
  • Dr. Dinesh Khanna
    Dinesh Khanna
    Article type: letter
    2023 Volume 85 Issue 4 Pages 315-316
    Published: August 01, 2023
    Released on J-STAGE: August 25, 2023
    DOIhttps://doi.org/10.2336/nishinihonhifu.85.315
    JOURNAL RESTRICTED ACCESS
    Show abstractHide abstract

    Dinesh Khanna, MD, MSc, is Professor of Medicine and Director, University of Michigan Scleroderma Program. He holds the Frederick G.L. Huetwell Professorship in Rheumatology. Dr. Khanna has published over 550 peer-reviewed articles and book chapters. He is the Principal Investigator on the National Institutes of Health and industry-sponsored clinical studies. He is the coordinating PI for investigator-initiated and pharmaceutical sponsored clinical trials in scleroderma that led to the regulatory approval of tocilizumab in scleroderma- associated interstitial lung disease. His current research focus on developing, validating, and refining outcome measures in rheumatic diseases and designing controlled trials. He is lead author of the scleroderma composite index (called ACR CRISS and Revised CRISS) that is undergoing regulatory review as an approvable endpoint. He received the prestigious 2015 Henry Kunkel Young Investigator Award from the American College of Rheumatology and was inducted in the 2023 American Society for Clinical Investigation.

    View full abstract
    Download PDF (2826K)
    • |<
    • <
    • 1
    • >
    • >|
feedback
 Top